Envelope glycoprotein GP340

BE0000712ProteinHHV-4

Responsible for EBV binding to the CR2 receptor on human B-cells. It is acted on by 1 drug in DrugBank.

UniProtKB entry
P68344Swiss-Prot
Cellular location
Virion membrane
Residues / weight
886 residues · 92,388 Da
Also known as
MA · Membrane antigen

Resolves to

Protein
UniProtP68344UniProt nameVGP3_EBVP3
Gene
GenBank291520
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Envelope glycoprotein GP340, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In